Skip to main content
. 2020 Jul 13;11(1):127–142. doi: 10.1016/j.apsb.2020.07.002

Figure 8.

Figure 8

Reduced liver injury and inflammation generation in db/m mice after anti-VEGFB/IL22 fusion protein therapy. (A) Representative images of H&E staining and images of oil red O staining (scale bar: 100 μm, 200 × ; 50 μm, 400 ×). (B) and (E) Immunoblotting and quantitative analysis of the expression of NLRP3 and cleaved caspase-1 in the liver (n = 3–5). (C) Quantification of oil red O analysis of liver sections (n = 3). (D) Measurements of serum ALT and serum AST (n = 5–7). ∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001; ∗∗∗∗P < 0.0001.